Position history for ARK Investment Management LLC's holdings in RECURSION PHARMACEUTICALS IN
ARK Investment Management LLC holds 40.2M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $123.5M as of 2026-Q1. The position was increased (+7.8% shares). RXRX represents 1.0% of ARK Investment Management LLC's portfolio.
Current Value
$123.5M
Current Shares
40.2M
Total Value Change
-$87.6M
Total Shares Change
+12.1M
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Increased |
| 40.2M |
+7.8% |
| $123.5M |
| 1.0% |
| $3.54 |
46 |
| 2025-Q4 | Increased | 37.3M | +11.2% | $152.6M | 1.0% | $4.11 | 53 |
| 2025-Q3 | Increased | 33.5M | +1.7% | $163.7M | 1.0% | $4.91 | 43 |
| 2025-Q2 | Decreased | 33M | -5.3% | $166.9M | 1.2% | $5.03 | 0 |
| 2025-Q1 | Increased | 34.8M | +7.6% | $184.2M | 1.8% | $5.81 | 52 |
| 2024-Q4 | Decreased | 32.3M | -1.3% | $218.7M | 1.8% | $6.77 | 0 |
| 2024-Q3 | Increased | 32.8M | +16.4% | $215.9M | 2.0% | $6.98 | 56 |
| 2024-Q2 | Increased | 28.1M | +14.5% | $211.1M | 1.9% | $7.50 | 55 |